Wereport a patient with a severe inclusion body myositis (IBM). His illness was unusual in terms of a rapid progression, high creatine kinase levels, and complication with interstitial pneumonia. He responded well to immunosuppressive agents such as corticosteroids, cyclosporin A, cyclophosphamide, and immunoglobulin. The present patient indicates the wide range of the disease, and that immunosuppressive agents may be useful for treatment of IBM. (Internal Medicine 40: 940-944, 2001) 
Introduction
Idiopathic inflammatory myopathy encompasses 3 major myositises, polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM) (1) . Among these, IBM is a rather new clinicopathological entity. Since IBMwas first described in 1971, the unique clinical features of IBMhave been disclosed such as insidious onset, slowly progressive course, painless muscleweakness,and the resistance to corticosteroid treatment (1 , 2) . The hallmark of IBMis intracytoplasmic and/ or intranuclear filamentous inclusions demonstrated by electron microscopy (1, 2). However,their nature remain unclear and they maynot be entirely specific for the disease, since various other neuromuscular disorders such as familial distal myopathies may occasionally have such inclusions (1 , 2). Fukuhara et al (3) reported oculopharyngeal muscular dystrophy and distal myopathy which occurred in different members of a family, and suggested that these neuromuscular disorders and IBMmay represent variants of the same disease (1, 3) . The degree of myositis observed in IBMvaries from almost none to quite severe (1) . In most cases, however, creatine kinase (CK) levels are within normal or mildly elevated (usually below 1,000 IU//), which is knownto be one of the characteristics of IBM(4). Although PM/DMis known to be associated with interstitial pneumonia, IBM is rarely complicated with interstitial pneumonia (2, 5, 6) . Wetreated a unique elderly patient with IBM,who showedrather rapid progression, markedly elevated levels of CKand complication with interstitial pneumonia. The patient was successfully treated with immunosuppressive agents.
Case Report
A 70-year-old man with weakness of muscle strength and dyspnea on effort (Hugh-Jones IV) was admitted to our hospital in May1999. The muscle weakness and dyspnea occurred a few months before admission. These symptoms had been objectively recognized by family members one month previously, and had gradually worsened. A few weeks earlier, he had some difficulty in swallowing of meals. This symptom had also been gradually exacerbated. His height was 166 cm and body weight 48 kg (body mass index: 17.4). He lost a further 6 kg of body weight during the initial two weeks after admission. He had symmetrical, proximal and distal muscle weakness without tenderness. Moderate atrophy of skeletal muscles was noted except for facial and extraocular regions. His deep tendon reflexes were obviously diminished, especially in the lower limbs. Fine crackles were audible on the lower margin of bilateral lungs. There were no skin or joint abnormalities. Arterial blood gas analysis on 4 //min of O2 via nasal cannula revealed pH 7.44, PaO2 97 Torr, PaCO2 44 Torr. The white cell count was 8,500/mm3 with 80.2% neutrophils, ll.2% lymphocytes, 7.0% monocytes, and 1.2% eosinophils. Erythrocyte sedimentation rate and C-reactive protein were mildly elevated (30 mm/h and 1.3 mg/dl, respectively). Levels of total CKand lactate dehydrogenase activity were 9,370 IU// (normal range 45 to 226 IU//) and 4,130 IU// (normal range 200 to 425 IU//), respectively. Aldolase level was within normal limit. Rheumatoid factor, anti-nuclear antibody, and anti-Jo-1 antibody were all negative. Serum KL-6 level was 630 U/ml (<500 U/ml). Chest X-ray film showed bilateral reticular shadows. Chest CT scans revealed consolidations with ground glass opacities in , these findings were greatly improved. These photos also demonstrate low-attenuation area with comb-like remnant interstitium in the peri-pleura, suggesting pulmonary emphysemaof the paraseptal type.
both lungs (Fig. 1A ). An electromyography showed mixed myopathic and neurogenic patterns. Echocardiography demonstrated pericardial effusion with normal cardiac function. Total cell count of bronchoalveolar lavage fluid (BALF) (recovery rate 57%; 85 ml/150 ml) was 5.3xlO5 cells/ml, with 54.5% macrophages, 35.3% lymphocytes (CD3: 98%, CD4: 2%, CD8: 97%, CD4/CD8 ratio: 0.02), 1.5% neutrophils and 8.8% eosinophils. Transbronchial lung biopsy specimens showed thickened alveolar septa and fibrosis with infiltration of lymphocytes. Specimens obtained from the left quadriceps muscle revealed small clusters of atrophic fibers, myonecrosis, muscle regeneration, sparse perifascicular infiltration of mononuclearcells, and vacuoles in muscle fibers by light microscopy ( Fig. 2A) . Electron microscopy showed inclusion body composed of filaments in nuclei (Fig. 2B) .
His illness was therefore diagnosed as IBMcomplicated with interstitial pneumonia. We administered methylprednisolone 1 g/day for three consecutive days ("pulse therapy") from June 12, followed by oral prednisolone 60 mg/day (Fig. 3) . Steroid therapy brought a moderate decrease in CKlevels. However, muscle involvement still progressed, as evidenced by high % creatinuria and gradual decrease in circumference of thigh. Furthermore, because of respiratory muscle weakness, he was intubated and controlled by mechanical ventilation. In addition to second steroid pulse therapy, we administrated intravenous immunoglobulin (IVIg) with doses of 0.4 g/kg for 5 days and started administration of cyclosporin A (trough level: 100-200 ng/ml) on June 26.
Serum CKlevels gradually decreased and muscle global atrophy stopped. After the intravenous administration of 500 mg of cyclophosphamide, serum CKlevels further decreased to the normal range. Abnormalities on chest CTscans were improved (Fig. IB) and he could breathe by himself on room air. In November 1999, he was able to walk by himself. During the tapering of the dose of prednisolone and cyclosporin A, the disease relapsed with elevated levels of serum CKand increased interstitial shadows on chest X-ray film. However, the relapse could be successfully treated by dosing up of cyclosporin A and corticosteroids including the third pulse therapy. He was discharged from our hospital to his homein March 2000.
Discussion
Wereported herein an unusual case of IBM.Someaspects of this patient are in accordance with clinical "prototype" of IBM, such as male predominance, occurrence in elderly population, painless muscle weakness, distal muscle involvement, relative resistance to corticosteroid therapy. Furthermore, dysphasia is a common symptomof IBM.However,the present patient is unusual in respect to the rapidly progressive course and markedly elevated serum CK levels. Patients with IBM typically show a mild increase of CKlevels. Moreover, the level of serum CKis within normal in about 20%of patients (2) . On the other hand, some patients with circulating CKlevels as high as 12,000 IU// have been reported, but the details were not described (2). The markedly high level of CK may be related with the relatively rapid progress of the disease observed in the present patient. Up to 15%of IBMis known to be associated with systemic autoimmunediseases such as systemic lupus erythematosus, rheumatoid arthritis, immunethrombocytopenia, and psoriasis (1, 2, 4) . Interstitial pneumonia is also reported as a rare complication of IBM. A review of 40 IBMpatients by Lotz et al included two patients with interstitial pneumonia (6) . However, the detailed information was not available. Interstitial pneumonia occurred in IBMpatients, but these patients seem to be due to complicating diseases such as sarcoidosis and dermatomyositis (7, 8) . In our patient, the deterioration of muscle strength and respiratory distress appeared almost simultaneously, indicating that the appearance of pulmonary lesions There is no standard treatment for patients with IBMat present. It is known that IBMis usually resistant to corticosteroids (1, 2). Since, some patients improved on the treatment of corticosteroids, we administered a high-dose methylprednisolone intravenously ("pulse therapy") in addition to 60 mg/day of oral prednisolone. These drugs were to some extent effective and reduced the serum CKlevels in the present patient. However,clinical signs and %creatinuria, a parameter of myositis ( 10), were further deteriorated in spite of these treatments. Since the condition of the patient becameworse and showed respiratory failure due to weakness of respiratory muscles, we used further anti-inflammatory treatment. IVIg has been re- ported to have anti-inflammatory effects and to help recovering muscle strength in patients with IBM and DM(ll, 12). There are somereports suggesting the usefulness of immunosuppressive agents such as prednisolone, azathioprine, methotrexate, cyclosporin and chlorambucil ( 1 3-15) , especially if there is evidence of an associated systemic autoimmunediseases or autoantibodies (4, 8, 13, 16) . These drugs are often useful in steroid-resistant PM/DM,which occurs 10-40% of the patients (17, 18) . Our patient seemed to respond well to immunosuppressive agents such as corticosteroids, cyclosporin A, cyclophosphamide, and immunoglobulin, supporting the notion that immunosuppressive agents maybe useful for the treatment of IBM.
